Continuous subcutaneous insulin infusion (CSII) therapy and the quality of life in patients with diabetes mellitus
Keywords:
insulin therapy, continuous subcutaneous insulin infusion, insulin pump, the quality of lifeAbstract
On the basis of the literature and the author’s own experiences, the advantages and drawbacks of insulin therapy by continuous subcutaneous infusion method using a personal insulin pump have been discussed. In order to achieve good effects of such treatment, the patient and/or his/her guardians must be highly motivated to take utmost care when following the treatment programme. Very good education and the possibility of keeping in touch (also via the telephone and electronic means) with the therapeutic and educational team is of crucial importance.
Downloads
References
ISPAD Clinical Practice Consensus Guidelines 2009. Pediatric Diabetes 2009;10 suppl. 12.
Kubicz A, Lisowicz L, Korczowski B.: Wpływ metody insulinoterapii na jakość życia młodzieży chorującej na cukrzycę typu 1. Przegląd Medyczny Uniwersytetu Rzeszowskiego Rzeszów 2008; 2:170–174
Sobczyk W., Gugała M., Rola R.: Rozwój badań nad jakością życia w chorobach przewlekłych. Post. Psychiatr. Neurol. 2008: 17 (4) S.353–356
Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2010 Stanowisko Polskiego Towarzystwa Diabetologicznego. DiabetologiaPraktyczna
Zegarlicka-Poreba M, Jarosz-Chobot P., Krajewska-Siuda E, Krajewski-Siuda K, Małecka-Tendera E.: Rozumienie zdrowia przez młodzież chorującą na cukrzycę typu 1 w oparciu o własne kryteria; Endokry. Diabeł. i Chor. Przem. Mat. Wieku. Roz. 2005; 11:91–95
Bangstad HJ, Danne T, Deeb L, Jarosz-Chobot P, Urakami T, Hanas R.: Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2009; 10 Suppl 12:82–99.
Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pánkowska E, Ludvigsson J. i wsp.: PedPump Study Group. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia. 2008; 51: 1594–1601.
Hammond P, Liebl A, Grunder S.: International survey of insulin pump users: Impact of continuous subcutaneous insulin infusion therapy on glucose control and quality of life. Prim Care Diabetes. 2007; 1:143–146.
Jarosz-Chobot P.: Zastosowanie ciągłego podskórnego wlewu insuliny(CSII) za pomocą osobistych pomp insulinowych w leczeniu dzieci i młodzieży chorych na cukrzycę typu1. Wiad Lek. 2004;57:263–266.
Jarosz-Chobot P.: Nowoczesna insulinoterapia. [w:] Cukrzyca w populacji wieku rozwojowego – co nowego? (red.) Otto-Buczkowska E. Cornetis Wrocław 2009:158–167.
Karagianni P, Sampanis Ch, Katsoulis Ch, Miserlis G, Polyzos S, Zografou I. i wsp.: Continuous subcutaneous insulin infusion versus multiple daily injections. Hippokratia. 2009;13:93–96.
Otto-Buczkowska E, Jarosz-Chobot P, Tucholski K. Nowoczesne metody leczenia i monitorowania cukrzycy typu 1. Endokrynol Pol. 2008; 59: 246–253
Otto-Buczkowska E., Janota A., Czupryniak A. Nowoczesne metody podawania insuliny i monitorowania glikemii w cukrzycy typu 1. Lekarz 2008;12: 68–72
Pańkowska E, Błazik M.: Bolus Calculator with Nutrition Database Software, a New Concept of Prandial Insulin Programming for Pump Users. J Diabetes Sci Technol. 2010;4:571–576.
Pickup JC, Harris A.: Assessing quality of life for new diabetes treatments and technologies: a simple patient-centered score. J Diabetes Sci Technol. 2007;1:394–399.
Bair MJ, Brizendine EJ, Ackermann RT, Shen C, Kroenke K, Marrero DG.: Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetes. Diabet Med. 2010;27:578–584.
de Wit M, Delemarre-van de Waal HA, Bokma JA, Haasnoot K, Houdijk MC, Gemke RJ, Snoek FJ.: Monitoring and discussing health-related quality of life in adolescents with type 1 diabetes improve psychosocial well-being: a randomized controlled trial. Diabetes Care. 2008;31:1521–1526.
Gawron A., Jarosz-Chobot P., Otto-Buczkowska E.: Przyczyny nieprawidłowego wyrównania metabolicznego u młodocianych chorych na cukrzycę typu 1. Lekarz 2010;14:62–70
Hanas R.: Cukrzyca typu1 u dzieci, młodzieży i dorosłych. Jak stać się znawcą swojej cukrzycy. Dia- Pol, Warszawa wyd. II 2010
Cameron FJ, Skinner TC, de Beaufort CE, Hoey H, Swift PG, Aanstoot H. i wsp.: Hvidoere Study Group on Childhood Diabetes. Are family factors universally related to metabolic outcomes in adolescents with Type 1 diabetes? Diabet Med. 2008;25:463–468.
Chaplin JE, Hanas R, Lind A, Tollig H, Wramner N, Lindblad B.: Assessment of childhood diabetes-related quality-of-life in West Sweden. Acta Paediatr. 2009; 98: 361–366.
Hanberger L, Ludvigsson J, Nordfeldt S.: Health-related quality of life in intensively treated young patients with type 1 diabetes. Pediatr Diabetes. 2009;10:374–381.
Nardi L, Zucchini S, D'Alberton F, Salardi S, Maltoni G, Bisacchi N,. i wsp.: Quality of life, psychological adjustment and metabolic control in youths with type 1 diabetes: a study with self- and parent-report questionnaires. Pediatr Diabetes. 2008;9:496–503
Naughton MJ, Ruggiero AM, Lawrence JM, Imperatore G, Klingensmith GJ, Waitzfelder B. i wsp.: SEARCH for Diabetes in Youth Study Group. Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study. Arch Pediatr Adolesc Med. 2008;162:649–657.
Przybysz M., Horodnicka-Józwa A., Petriczko E., Wójcik K., Walczak M.: Ocena jakości życia dzieci z cukrzycą typu 1. Endokrynologia Pediatryczna 2008;7: 26.
Petrak F, Herpertz S.: Treatment of depression in diabetes: an update. Curr Opin Psychiatry. 2009;22:211–217.
Stewart SM, Rao U, White P.: Depression and diabetes in children and adolescents. Curr Opin Pediatr. 2005;17:626–631
Pietrzykowska E., Majchrzak A., Piłacinski S., Wierusz-Wysocka B.: Style radzenia sobie ze stresem a kontrola glikemii i samokontrola choroby u pacjentów z nowo rozpoznaną cukrzycą typu 1, leczonych metodą intensywnej czynnościowej insulinoterapii. V Karpacka Konferencja Diabetologiczna. Wisła 2010 , U2.
Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE.: Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med. 2005;22: 1379–1385.
Szewczyk A.: Rola edukatorów w procesie leczenia dzieci i młodych dorosłych chorych na cukrzycę w świetle przepisów i praktyki. [w] Cukrzyca w populacji wieku rozwojowego – co nowego? (red.) Otto-Buczkowska E. Cornetis Wrocław 2009:233–243.
Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A. i wsp.: In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med. 2008;25:326–332.
Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, Palmer AJ.: Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia. Pharmacoeconomics. 2007; 25:881–897.
EQuality1 Study Group--Evaluation of QUALITY of Life and Costs in Diabetes Type 1, Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F. i wsp. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med. 2008;25:213–220.
Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab. 2009; 94: 729–740.
Home PD, Capaldo B, Burrin JM, Worth R, Alberti KG. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injection in insulin – dependent diabetic subject: improved control with CSII. Diabetes Care 1982; 5:466–471.
Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP. i wsp.; 5-Nations Study Group. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med. 2006; 23:141–147.
Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM. i wsp.: German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med. 2008 ;25:80–85.
Pfeiffer EF, Thun C, Clemens AH.: The artificial beta cell. A continuous control of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res 1974;6:339–342.
Pickup J, Keen H.: Continuous subcutaneous insulin infusion at 25 years; evicence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25:593–598.
Benbenek-Klupa T.: Jak przygotować pacjenta do leczenia osobistą pompą insulinową, Kardiodiabetologia 2006: 6:25–27,
Benbenek-Klupa T.: Edukacja pacjenta przygotowywanego do terapii z zastosowaniem osobistej pompy insulinowej. Przegl.Lek. 2006; 5: 292–295
Panasiuk K, Załuska W, Makara-Studzińska M.: Pompa insulinowa w leczeniu cukrzycy typu 1. Zdrowie Publiczne 2008;118:91–95.
Pańkowska E, Zasady postępowania w leczeniu pompami insulinowymi dzieci z cukrzycą typu1. Klinika Pediatrii 2008; 16:5080–5084.
Tatoń J. Łaz R.: Intensywna insulinoterapia za pomocą pompy insulinowej w układzie otwartym: nowe wskazania i ulepszenia techniczne. Medycyna Metaboliczna 2007; 11:86–95
Pickup JC, Sutton AJ.: Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25:765–774.
Scheidegger U, Allemann S, Scheidegger K, Diem P. Continuous subcutaneous insulin infusion therapy: effects on quality of life. Swiss Med Wkly. 2007;137:476–482.
Tucholski K, Deja G, Skała-Zamorowska E, Jarosz-Chobot P.: Evaluation of daily glycemic profiles in well controlled children with type 1 diabetes mellitus using a continuous glucose monitoring system. Pediatr Endocrinol Diabetes Metab. 2009;15:29–33.
Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadr R.: Insulin pump therapy. A meta-analysis. Diabetes Care 2003; 26: 1079–1087.
Pańkowska E, Szypowska A, Lipka M, Szpotańska M, Błazik M, Groele L.: Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes. Pediatr Diabetes. 2009; 10:298–303.
Olinder AL, Kernell A, Smide B.: Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes. Pediatr Diabetes. 2009; 10:142–148.
Minkina-Pedras M, Jarosz-Chobot P, Małecka-Tendera E, Deja G.: [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11:171–176
Minkina-Pedras M, Jarosz-Chobot P, Polanska J, Kalina MA, Marcinkowski A, Malecka-Tendera E.: Prospective assessment of continuous subcutaneous insulin infusion therapy in young children with type 1 diabetes. Diabetes Res Clin Pract. 2009;85:153–158.
Opipari-Arrigan L, Fredericks EM, Burkhart N, Dale L, Hodge M, Foster C.: Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus. Pediatr Diabetes. 2007;8:377–383.
Noczyńska A.: Ciągły podskórny wlew insuliny u dzieci z cukrzycą typu1. Medycyna Metaboliczna 2009, 13:58–61.
Otto Buczkowska E, Dworzecki T, Wiedermann G, Malanowicz B, Szot D.: Doświadczenia w zastosowaniu ciągłego podskórnego wlewu insuliny (CPWI) w leczeniu cukrzycy u młodocianych chorych. Przegl. Lek. 2005;62:49–53.
Cyganek K, Hebda-Szydlo A, Katra B, Skupien J, Klupa T, Janas I, i wsp.: Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol Ther. 2010;12:41–47.
St Charles ME, Sadri H, Minshall ME, Tunis SL.: Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada. Clin Ther. 2009;31:657–667.
Jarosz-Chobot P, Nowakowska M, Polanska J.: Seeking the factors predisposing to local skin inflammatory state development in children with type 1 diabetes (T1DM) treated with continuous subcutaneous insulin infusion (CSII). Exp Clin Endocrinol Diabetes. 2007;115:179–181.
Nowakowska M, Jarosz-Chobot P, Polańska J, Machnica Ł.: Bacterial strains colonizing subcutaneous catheters of personal insulin pumps. Pol J Microbiol. 2007;56:239–243.
Conwell LS, Pope E, Artiles AM, Mohanta A, Daneman A, Daneman D.: Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr. 2008;152:622–628.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2010 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
